Pralatrexate FDA approval date

The FDA approved Pralatrexate (Folotyn®) on 24 Sep 2009.

FDA approval date
24 Sep 2009

Drug identity checked against registry records

Also recorded as Folotyn®

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2009-09-24DayPralatrexateFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022468", "applicant_as_listed_by_fda": "ACROTECH BIOPHARMA", "brand_names": ["FOLOTYN"], "active_ingredients": ["PRALATREXATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090924", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026